Kimia
therapeutics

The future of drug discovery

Unlocking deeper insights from empirical data in the pursuit of better medicines.
Read our most recent news here.

Get the App
Aenean Consectetur Porta

At Kimia, we are using Chemotype Evolution to generate extensive datasets that reveal the molecular features of active and inactive drug molecules. By mining these datasets through machine learning we can generate algorithms and feature maps to help accelerate the discovery of drugs for novel and challenging targets. Our mission is to bring better therapies to patients faster to give them the options they deserve.

Aenean Consectetur

Using a chemical starting point called a "bait," Chemotype Evolution enables rapid synthesis and screening of target-focused libraries, thereby providing relevant and information-rich datasets ideally suited for machine learning. Ideas generated from machine learning are then used to design new iterations of Chemotype Evolution, creating synergistic cycles of data generation and data mining. The combination of Chemotype Evolution and machine learning allows Kimia to explore vast chemical diversity with unprecedented speed, thus improving the probability of success in the drug discovery process.

Chemotype Evolution
Bait
Drug
Machine Learning & Computational Design
ConsectUltricies

Amet Ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Activity Notifications

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Custom Timing

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Mobile Optimized

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

+12k

Nibh Elit Tristique

84

Aenean Condimentum

3,07

Quam Inceptos

24h

Ullamcorper

Aenean Consectetur Porta

Parturient Tortor

Nulla vitae elit libero, a pharetra augue. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Cras mattis consectetur purus sit amet fermentum. Donec id elit non mi porta gravida at eget metus. Etiam porta sem malesuada magna mollis euismod.

HeadNulla vitae elit libero, a pharetra augue. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Pus sit amet fermentum. Donec id elit non mi porta gravida at eget metus. Etiam porta sem malesuada magna mollis euismod.ing

Joshua Home

New York Times

HeadNulla vitae elit libero, a pharetra augue. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Pus sit amet fermentum. Donec id elit non mi porta gravida at eget metus. Etiam porta sem malesuada magna mollis euismod.ing

Nulla vitae elit libero, a pharetra augue.

New York Times

Aenean Consectetur Porta

The druggable proteome is vast and under explored, presenting an immense opportunity for the future of drug discovery. Kimia is building an integrated platform to map the covalently druggable proteome in cancer cells. Using a combination of covalent Chemotype Evolution, chemo-proteomics, transcriptomics, and machine learning, Kimia will be able to identify novel targets and drug leads, opening up a new frontier in therapeutic discovery.

Aenean Consectetur Porta

At Kimia, we are using Chemotype Evolution to uncover the molecular features of binding sites for drug molecules. By mining this data through machine learning and computational design we accelerate the discovery of drugs for novel and challenging targets.

Interested in learning more about Kimia?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.